More Investing
View Older Stories View Newer Stories-
Lockheed’s F-35 jets to cost Canada 50% more than planned, Auditor General says
-
JP Morgan downgrades Informa TechTarget and cuts price target by over 50%
-
CoreWeave falls as DA Davidson projects equity worth less than $5/share
-
Citi adds Qorvo and Skyworks Solutions to 90-day upside catalyst watch
-
OpenAI to use Google cloud service alongside Microsoft
-
GLP-1 appetite suppression turns Redburn bearish on McDonald's, Domino's
-
Here’s why Citi says Apple stock is ’set up well’ for 2026
-
Gilead Sciences shares hit after HIV studies placed on hold by FDA
-
Blackstone reportedly mulls IPO for Spanish casino operator Cirsa
-
BofA institutional clients dump stocks at historic rate, retail keeps buying
-
BofA double downgrades Renk on ’full valuation’
-
UBS stock tumbles on capital concerns
-
Paramount Global reduces U.S. staff by 3.5% amid industry challenges - report
-
Tesla’s Q2 deliveries on track for another poor quarter: Wells Fargo
-
Xometry (XMTR) stock falls on convertible notes offering plans
-
Cracker Barrel (CBRL) stock tumbles on convertible notes offering
-
Tesla shares gain as Trump wishes Musk ’well’
-
GFL weighs sale in infrastructure arm valued at C$5 billion - Bloomberg
-
Apple’s WWDC called a ’yawner’ amid delayed AI progress
-
Sitio Royalties downgraded after Viper Energy agrees to acquire co for $19.41/shr
-
Intuitive Surgical cut to sell at Deutsche Bank
-
Eduction stock sinks amid proposed Pell Grant cuts
-
Hong Kong’s 707 Cayman (JEM) opens at $3.98, IPO priced at $4
-
Wolfe Research downgrades Equinix on valuation concerns after strong rally
-
NVIDIA stock gains as Huang kicks off European tour with UK his first stop
-
BNP Paribas Exane dubs Goodyear "tariff winner," shares surge
-
Goldman Sachs downgrades General Mills, Conagra on cost pressures, weak demand
-
Wall Street analysts initiate coverage of eToro
-
MS downgrades McDonald's on limited upside and structural pressures on fast food
-
Ondas Holdings stock soars on major defense order
-
PolyPid (PYPD) shares surge on successful D-PLEX100 trial results
-
TuHURA Biosciences (HURA) stock rises following FDA hold lift
-
Elevation Oncology (ELEV) stock soars on Concentra merger agreement
-
IonQ (IONQ) stock rises following Oxford Ionics acquisition deal
-
Chewy set-up into and post Q1 results is ’increasingly less attractive’
-
Muted expectations in Canadian sectors show room for positive surprises - BMO
-
Goldman Sachs downgrades Mobileye on limited market share, competitive pressure
-
Tata Motors plans $4.1 billion investment in new models, EV production
-
GM's (GM) Cadillac unveils the 2026 OPTIQ-V
-
Jefferies sees upside for Oracle stock on strong RPO momentum
-
Interactive Brokers hit by Citi downgrade as valuation climbs but Redburn ups PT
-
Citius Oncology (CTOR) stock soars on distribution deal
-
Niagen Bioscience (NAGE) stock rises following positive clinical study
-
What are the three big things in markets now? RBC weighs in
-
Morgan Stanley downgrades Lululemon on weak US growth outlook
-
AppLovin would be more valuable without its 1P games, Morgan Stanley argues
-
London-listed Spectris soars 20% on fresh takeover interest from Advent
-
Tesla downgraded as 'uncertainty abounds'
-
Echostar stock sinks amid bankruptcy considerations
-
Warner Bros. Discovery to split into two media companies
